CLINICAL_TRIALS
trial_result
· 2025-05-02
Clinical Trial Update: Anti-epileptogenic Effects of Eslicarbazepine Acetate [Phase 2]
Summary
Phase 2 trial evaluating anti-epileptogenic effects of eslicarbazepine acetate in post-stroke epilepsy completed, with results posted on 2025-05-02.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bial - Portela C S.A. | Conditions: Post Stroke Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2025-05-02